01.03.2014 | Erratum
Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy
Erschienen in: Annals of Hematology | Ausgabe 3/2014
Einloggen, um Zugang zu erhalten